AFROCENTRIC INVESTMENT CORP LIMITED - Disclosure of change in shareholding
ACT 201610270008A
Disclosure of change in shareholding
AFROCENTRIC INVESTMENT CORPORATION LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 1988/000570/06)
JSE Code: ACT
ISIN: ZAE000078416
(“AfroCentric” or “the Company”)
DISCLOSURE OF AN ACQUISITION OF SECURITIES
In accordance with section 122(3)(b) of the Companies Act, Act 71 of 2008, as
amended, and paragraph 3.83(b) of the JSE Limited Listings Requirements,
shareholders are advised that the Company has been notified that ARC Health (Pty)
Limited (“ARCH”) has acquired a beneficial interest in the securities of the Company
(“Acquisition”).
Following the Acquisition, ARCH now holds a 5.592% beneficial interest in the total
issued share capital of the Company.
Johannesburg
27 October 2016
Sponsor: Sasfin Capital (a division of Sasfin Bank Limited)
Date: 27/10/2016 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
